Kolon TissueGene, Inc. (KOSDAQ:950160)

Market Cap	3.71T
Revenue	n/a
Net Income	n/a
Shares Out	81.52M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	557,547
Average Volume	394,357
Open	46,500
Previous Close	45,450
Day's Range	41,500 - 46,900
52-Week Range	11,250 - 59,300
Beta	-0.77
RSI	50.75
Earnings Date	n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950160